Dopamine receptor D3

3PBL181413490ENSG00000151577ENSMUSG00000022705P35462P30728NM_033660NM_033663NM_007877NP_000787NP_001269492NP_001277738NP_387512NP_031903Dopamine receptor D3 is a protein that in humans is encoded by the DRD3 gene. Dopamine receptor D3 is a protein that in humans is encoded by the DRD3 gene. This gene encodes the D3 subtype of the dopamine receptor. The D3 subtype inhibits adenylyl cyclase through inhibitory G-proteins. This receptor is expressed in phylogenetically older regions of the brain, suggesting that this receptor plays a role in cognitive and emotional functions. It is a target for drugs which treat schizophrenia, drug addiction, and Parkinson's disease. Alternative splicing of this gene results in multiple transcript variants that would encode different isoforms, although some variants may be subject to nonsense-mediated decay (NMD). D3 agonists like 7-OH-DPAT, pramipexole, and rotigotine, among others, display antidepressant effects in rodent models of depression D3 agonists have been shown to disrupt prepulse inhibition of startle (PPI), a cross-species measure that recapitulates deficits in sensorimotor gating in neuropsychiatric disorders such as schizophrenia. In contrast, D3-preferring antagonists have antipsychotic-like profiles in measures of PPI in rats. Dopamine receptor D3 has been shown to interact with CLIC6 and EPB41L1. This article incorporates text from the United States National Library of Medicine, which is in the public domain.